STOCK TITAN

Phibro Animal Health Corporation - PAHC STOCK NEWS

Welcome to our dedicated page for Phibro Animal Health Corporation news (Ticker: PAHC), a resource for investors and traders seeking the latest updates and insights on Phibro Animal Health Corporation stock.

Phibro Animal Health Corporation (Class A, symbol: PAHC) is a leading global company specializing in animal health and mineral nutrition. With over 40 years of experience, Phibro is dedicated to meeting the rising demand for animal protein by focusing solely on animals used in food production. The company offers a comprehensive range of products for poultry, swine, beef and dairy cattle, and aquaculture.

Phibro's core business involves the development, manufacturing, and marketing of products designed to prevent, control, and treat animal diseases, enhance nutrition, and contribute to balanced mineral nutrition. Their product portfolio includes antibacterials, anticoccidials, nutritional specialty products, and vaccines. The company's operations are divided into three segments: Animal Health, Mineral Nutrition, and Performance Products, with the Animal Health segment being the primary revenue driver.

In the fiscal year ending June 30, 2017, Phibro reported net sales of $764 million. The company employs over 1,400 professionals who are committed to delivering value-based solutions to livestock producers, helping them maintain and enhance the health of their animals. Phibro's products are sold both in the United States and internationally, demonstrating its significant global footprint.

Recent achievements and ongoing projects by Phibro include the development of new vaccines and nutritional specialties aimed at improving animal health and productivity. The company continues to partner with various stakeholders in the livestock industry to innovate and provide sustainable solutions.

Phibro's financial condition remains robust, supported by consistent revenue streams from its diversified product offerings. The company’s focus on research and development underscores its commitment to advancing animal health technologies and addressing the evolving needs of the livestock industry.

For the latest news and updates, Phibro Animal Health Corporation remains a key player in the animal health sector, reflecting its dedication to enhancing the well-being of food animals globally.

Rhea-AI Summary
Phibro Animal Health Corporation (Nasdaq: PAHC) announced Q1 financial results, showing a 1% decrease in net sales to $231.3 million and a net loss of $8.0 million. Adjusted EBITDA decreased by 16% to $18.7 million. The company updated its fiscal year 2024 guidance, expecting net sales of $980 million to $1.02 billion and adjusted EBITDA of $106 million to $112 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.52%
Tags
-
Rhea-AI Summary
Phibro Animal Health Corporation (NASDAQ: PAHC) has received two actions from the FDA regarding Mecadox® (carbadox). The FDA has issued a final order to revoke the approved method for detecting residues of carbadox and proposed to withdraw approval of all new animal drug applications providing for the use of carbadox in medicated swine feed. Phibro believes in the safety of Mecadox and is disappointed in the FDA's actions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
none
-
Rhea-AI Summary
Phibro Animal Health Corporation (Nasdaq:PAHC) has declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock. The dividend is payable on December 20, 2023, to stockholders of record as of November 29, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.06%
Tags
dividends
Rhea-AI Summary
Phibro Animal Health Corporation to announce first quarter financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
conferences earnings
-
Rhea-AI Summary
TerraCycle Inc. announces Damian Finio as the new Chief Financial Officer, effective October 2. Finio brings over 30 years of financial management experience and will succeed Javier Daly, who will retire in early 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.87%
Tags
management
-
Rhea-AI Summary
Phibro Animal Health Corporation announces CFO resignation and interim replacement
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.87%
Tags
none
Rhea-AI Summary
Phibro Animal Health Corporation announces financial results for Q4 and FY2023, provides guidance for FY2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.93%
Tags
-
Rhea-AI Summary
Phibro Animal Health Corporation (Nasdaq: PAHC) to announce Q4 and fiscal year 2023 financial results on August 30, 2023. Conference call and webcast scheduled for August 31, 2023, at 9:00 AM ET. Interested parties can access the call and presentation slides at http://investors.pahc.com or by dialing +1 (888) 330-2022 (U.S. and Canada) or +1 (365) 977-0051 (international callers) using conference ID 3927884. Webcast replay available at https://investors.pahc.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.42%
Tags
conferences earnings
-
Rhea-AI Summary
Phibro Animal Health Corporation (PAHC) has announced a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock. The dividend will be payable on September 27, 2023, to stockholders of record as of September 6, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.23%
Tags
dividends
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.69%
Tags
none

FAQ

What is the current stock price of Phibro Animal Health Corporation (PAHC)?

The current stock price of Phibro Animal Health Corporation (PAHC) is $21.64 as of December 24, 2024.

What is the market cap of Phibro Animal Health Corporation (PAHC)?

The market cap of Phibro Animal Health Corporation (PAHC) is approximately 876.5M.

What does Phibro Animal Health Corporation do?

Phibro Animal Health Corporation develops, manufactures, and markets a broad range of animal health and mineral nutrition products for food animals.

Which animals does Phibro's products cater to?

Phibro's products are designed for poultry, swine, beef and dairy cattle, and aquaculture.

What are the main product categories of Phibro Animal Health Corporation?

The main product categories include antibacterials, anticoccidials, nutritional specialty products, vaccines, and mineral nutrition products.

How many employees does Phibro Animal Health Corporation have?

Phibro employs over 1,400 professionals.

How much revenue did Phibro report for the fiscal year ending June 30, 2017?

Phibro reported net sales of $764 million for the fiscal year ending June 30, 2017.

What are the primary segments of Phibro's operations?

Phibro operates through three primary segments: Animal Health, Mineral Nutrition, and Performance Products.

Where does Phibro sell its products?

Phibro sells its products in the U.S. and international markets.

What recent projects is Phibro involved in?

Phibro is involved in developing new vaccines and nutritional specialties aimed at improving animal health and productivity.

Who are Phibro's primary customers?

Phibro's primary customers are livestock producers who use their products to maintain and enhance the health of their animals.

What drives Phibro's revenue?

The Animal Health segment, which includes antibacterials, nutritional specialty products, and vaccines, is the key revenue driver for Phibro.

Phibro Animal Health Corporation

Nasdaq:PAHC

PAHC Rankings

PAHC Stock Data

876.50M
20.22M
0.57%
105.12%
1.14%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TEANECK